Literature DB >> 26946324

Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.

Cristina Tintori1, Angela Corona2, Francesca Esposito2, Annalaura Brai1, Nicole Grandi2, Elisa Rita Ceresola3,4, Massimo Clementi3, Filippo Canducci3,4, Enzo Tramontano5, Maurizio Botta6.   

Abstract

Because HIV-1 reverse transcriptase is an enzyme whose catalytic activity depends on its heterodimeric structure, this system could be a target for inhibitors that perturb the interactions between the protein subunits, p51 and p66. We previously demonstrated that the small molecule MAS0 reduced the association of the two RT subunits and simultaneously inhibited both the polymerase and ribonuclease H activities. In this study, some analogues of MAS0 were rationally selected by docking studies and evaluated in vitro for their ability to disrupt dimeric assembly. Two inhibitors were identified with improved activity compared to MAS0. This study lays the basis for the rational design of more potent inhibitors of RT dimerization.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV-1 reverse transcriptase; dimerization inhibitors; protein-protein interaction; virtual screening; viruses

Mesh:

Substances:

Year:  2016        PMID: 26946324     DOI: 10.1002/cbic.201500668

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  8 in total

1.  Peptides Mimicking the β7/β8 Loop of HIV-1 Reverse Transcriptase p51 as "Hotspot-Targeted" Dimerization Inhibitors.

Authors:  Pedro A Sánchez-Murcia; Sonia de Castro; Carlos García-Aparicio; M Angeles Jiménez; Angela Corona; Enzo Tramontano; Nicolas Sluis-Cremer; Luis Menéndez-Arias; Sonsoles Velázquez; Federico Gago; María-José Camarasa
Journal:  ACS Med Chem Lett       Date:  2020-01-24       Impact factor: 4.345

2.  Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.

Authors:  Angela Corona; Valentina Onnis; Alessandro Deplano; Giulia Bianco; Monica Demurtas; Simona Distinto; Yung-Chi Cheng; Stefano Alcaro; Francesca Esposito; Enzo Tramontano
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

Review 3.  Avoiding Drug Resistance in HIV Reverse Transcriptase.

Authors:  Maria E Cilento; Karen A Kirby; Stefan G Sarafianos
Journal:  Chem Rev       Date:  2021-01-28       Impact factor: 60.622

4.  Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

Authors:  Cristina Tintori; Giulia Iovenitti; Elisa Rita Ceresola; Roberto Ferrarese; Claudio Zamperini; Annalaura Brai; Giulio Poli; Elena Dreassi; Valeria Cagno; David Lembo; Filippo Canducci; Maurizio Botta
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

Review 5.  Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.

Authors:  Olga Tarasova; Vladimir Poroikov; Alexander Veselovsky
Journal:  Molecules       Date:  2018-05-21       Impact factor: 4.411

6.  From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.

Authors:  Serena Massari; Angela Corona; Simona Distinto; Jenny Desantis; Alessia Caredda; Stefano Sabatini; Giuseppe Manfroni; Tommaso Felicetti; Violetta Cecchetti; Christophe Pannecouque; Elias Maccioni; Enzo Tramontano; Oriana Tabarrini
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.

Authors:  Angela Corona; Valentina Onnis; Claudia Del Vecchio; Francesca Esposito; Yung-Chi Cheng; Enzo Tramontano
Journal:  Molecules       Date:  2020-03-15       Impact factor: 4.411

8.  Scaffold hopping and optimisation of 3',4'-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H.

Authors:  Graziella Tocco; Francesca Esposito; Pierluigi Caboni; Antonio Laus; John A Beutler; Jennifer A Wilson; Angela Corona; Stuart F J Le Grice; Enzo Tramontano
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.